Abstract:Effective strategies are needed to deal with invasive fungal infections caused by drug-resistant fungi. Previously, we designed a series of antifungal benzocyclane derivatives based on the drug repurposing of haloperidol. Herein, further structural optimization and antifungal mechanism studies were performed, leading to the discovery of new piperidol derivative B2 with improved synergistic antifungal potency, selectivity, and water solubility. In particular, the combination of compound B2 and fluconazole showed potent in vitro and in vivo antifungal activity against azole-resistant Candida albicans. Compound B2 inhibited important virulence factors by regulating virulence-associated genes and improved the efficacy of fluconazole by down-regulating the CYP51-coding gene and efflux pump gene. Taken together, the piperidol derivative B2 represents a promising lead compound for the combinational treatment of azole-resistant candidiasis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsinfecdis.0c00849?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00849</a>.Discussions of strains, culture, and agents used, mature biofilm destruction assay, real-time RT-PCR analysis, HTRF assay, water solubility test, and chemical synthesis and structural characterization, figures of biofilm formation percentages compared to the untreated groups, dose response curves, 1H and 13C NMR spectra, ESI-HRMS spectra, and HPLC spectra, table of primers for real-time RT-PCR, and schemes of synthetic pathways (<a class="ext-link" href="/doi/suppl/10.1021/acsinfecdis.0c00849/suppl_file/id0c00849_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Discovery of highly potent triazoleantifungal agents with piperidine-oxadiazole side chains

Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains.

Discovery of Novel Tetrazoles Featuring a Pyrazole Moiety as Potent and Highly Selective Antifungal Agents

Design, synthesis and in vitro biological studies of novel triazoles with potent and broad-spectrum antifungal activity

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design, synthesis, and evaluation of novel tetrazoles featuring isoxazole moiety as highly selective antifungal agents

Design, Synthesis, and In Vitro and In Vivo Antifungal Activity of Novel Triazoles Containing Phenylethynyl Pyrazole Side Chains

Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis

Discovery of a Novel Potent Tetrazole Antifungal Candidate with High Selectivity and Broad Spectrum

Synthesis and Antifungal Activity of Triazole Derivatives with Side Chain Containing Tert-Butyl and 4-Substitued-piperazin-1-yl

Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on Iodiconazole

Design, synthesis, and in vitro evaluation of novel antifungal triazoles containing substituted 1,2,3-triazole-methoxyl side chains

From Synergy to Monotherapy: Discovery of Novel 2,4,6-Trisubstituted Triazine Hydrazone Derivatives with Potent Antifungal Potency In Vitro and In Vivo

Synthesis and Antifungal Activity of 1-(1H-1,2,4-triazol-1-yl)-2-(3,3-dimethyl)-3-[(4-substituted)-piperazin-1-yl]-2-propanols

From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents.

Identification of novel and potent triazoles targeting CYP51 for antifungal: Design, synthesis, and biological study

Design,Synthesis and Antifungal Activity of Novel Pyrazole-Thiophene Carboxamide Derivatives

Design, Synthesis and Molecular Docking Studies of Novel Triazole Antifungal Compounds

Discovery of Novel α,β-Unsaturated Amide Derivatives as Candidate Antifungals to Overcome Fungal Resistance

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Discovery of Novel Thiosemicarbazides Containing 1,3,5-Triazines Derivatives as Potential Synergists against Fluconazole-Resistant Candida albicans